Suchergebnisse - "Kaochar, Salma"

PubPharm (41)

1

Assessment of Patient-Derived Xenograft Growth and Antitumor Activity : The NCI PDXNet Consensus Recommendations

enthalten in: Molecular cancer therapeutics | 2024

von Meric-Bernstam, F. | Lloyd, M. | Koc, S. | +31

2

Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiency

enthalten in: Research square | 2024

von Szallasi, Z. | Diossy, M. | Tisza, V. | +32

3

Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiency

enthalten in: ResearchSquare.com | 2024

von Szallasi, Z. | Diossy, M. | Tisza, V. | +32

4

Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis

enthalten in: Gut | 2024

von El-Serag, H. | Kanwal, F. | Ning, J. | +19

5

ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer

enthalten in: bioRxiv.org | 2023

von Qian, C. | Yang, Q. | Rotinen, M. | +23

6

ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer

enthalten in: bioRxiv : the preprint server for biology | 2023

von Qian, C. | Yang, Q. | Rotinen, M. | +23

7

SubclonalCHD1deletion is more frequent in African American prostate cancers and associated with rapid disease progression and limited levels of homologous recombination deficiency

enthalten in: bioRxiv.org | 2023

von Diossy, M. | Tisza, V. | Li, H. | +31

8

NOVEL INHIBITORS OF HISTONE ACETYLTRANSFERASE P300/CBP FOR CANCER THERAPY

enthalten in: Europäisches Patentamt | 2023

von SONG YONGCHENG | WU FANGRUI | NIE SHENYOU | +4

9

NOVEL INHIBITORS OF HISTONE ACETYLTRANSFERASE P300/CBP FOR CANCER THERAPY

enthalten in: Europäisches Patentamt | 2023

von SONG YONGCHENG | WU FANGRUI | NIE SHEN-YOU | +4

10

A path to translation : How 3D patient tumor avatars enable next generation precision oncology

enthalten in: Cancer cell | 2022

von Bose, S. | Barroso, M. | Chheda, M. | +23

1
2
3
4
5
Nächster »
[5]